JP2004535178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535178A5 JP2004535178A5 JP2002587594A JP2002587594A JP2004535178A5 JP 2004535178 A5 JP2004535178 A5 JP 2004535178A5 JP 2002587594 A JP2002587594 A JP 2002587594A JP 2002587594 A JP2002587594 A JP 2002587594A JP 2004535178 A5 JP2004535178 A5 JP 2004535178A5
- Authority
- JP
- Japan
- Prior art keywords
- sodium channel
- polypeptide
- nucleic acid
- isolated
- epilepsy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR4922A AUPR492201A0 (en) | 2001-05-10 | 2001-05-10 | Novel mutation |
| PCT/AU2002/000581 WO2002090532A1 (en) | 2001-05-10 | 2002-05-09 | Novel mutation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004535178A JP2004535178A (ja) | 2004-11-25 |
| JP2004535178A5 true JP2004535178A5 (enExample) | 2005-08-18 |
Family
ID=3828909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002587594A Abandoned JP2004535178A (ja) | 2001-05-10 | 2002-05-09 | 新規変異 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040191791A1 (enExample) |
| EP (1) | EP1385945A4 (enExample) |
| JP (1) | JP2004535178A (enExample) |
| AU (1) | AUPR492201A0 (enExample) |
| CA (1) | CA2446838A1 (enExample) |
| WO (1) | WO2002090532A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ530258A (en) | 2001-07-18 | 2006-01-27 | Bionomics Ltd | Mutations in SCN1A SCN2A SCN3A SCN8A sodium ion channels and their use in diagnosing epilepsy |
| WO2008079412A2 (en) * | 2006-12-22 | 2008-07-03 | The Trustees Of Columbia University In The City Of New York | Methods and compositions to treat arrhythmias |
| EA201992358A1 (ru) | 2017-04-03 | 2020-03-24 | Инкоудид Терапьютикс, Инк. | Тканеселективная экспрессия трансгена |
| JP7401432B2 (ja) | 2017-12-01 | 2023-12-19 | エンコーデッド セラピューティクス， インコーポレイテッド | 操作されたｄｎａ結合タンパク質 |
| WO2020243651A1 (en) | 2019-05-29 | 2020-12-03 | Encoded Therapeutics, Inc. | Compositions and methods for selective gene regulation |
| WO2024038160A1 (en) * | 2022-08-18 | 2024-02-22 | Vib Vzw | Means and methods to modulate neuron excitability |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000063367A1 (en) * | 1999-04-15 | 2000-10-26 | Warner-Lambert Company | A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| AU1846501A (en) * | 1999-11-26 | 2001-06-04 | Bionomics Limited | Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
-
2001
- 2001-05-10 AU AUPR4922A patent/AUPR492201A0/en not_active Abandoned
-
2002
- 2002-05-09 US US10/477,272 patent/US20040191791A1/en not_active Abandoned
- 2002-05-09 EP EP02721852A patent/EP1385945A4/en not_active Withdrawn
- 2002-05-09 CA CA002446838A patent/CA2446838A1/en not_active Abandoned
- 2002-05-09 JP JP2002587594A patent/JP2004535178A/ja not_active Abandoned
- 2002-05-09 WO PCT/AU2002/000581 patent/WO2002090532A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6904707B2 (ja) | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 | |
| Lee et al. | Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies | |
| KR102073034B1 (ko) | 항cxcr3 항체 | |
| EP2021016B1 (en) | Cxcl-13 antagonists and tnf-alpha antagonists for use in a combination therapy | |
| Pullen et al. | Pharmacological characterization of PF‐00547659, an anti‐human MAdCAM monoclonal antibody | |
| SK4512002A3 (en) | April-r antagonist for the treatment of diseases related to undesirable cell proliferation | |
| RS56268B1 (sr) | Monoklonalno antitelo protiv interleukina-31 kod pasa | |
| JPH10510709A (ja) | 摂食行動を変える方法、該方法に有用な化合物、および視床下部の異型神経ペプチドｙ／ペプチドｙｙ受容体（ｙ５）をコードするｄｎａ | |
| US20050014687A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
| WO2005070965A2 (en) | Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases | |
| JP2015187135A (ja) | 神経疾患の処置方法 | |
| EP1351968B1 (en) | Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus | |
| CA2454073A1 (en) | Mutations in ion channels | |
| JP2004500126A5 (enExample) | ||
| JP2006524490A5 (enExample) | ||
| CN105764527A (zh) | 新b细胞细胞因子的鉴定 | |
| US20110123535A1 (en) | Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival | |
| JP2004500126A (ja) | てんかんに関係する突然変異 | |
| WO2022093641A1 (en) | Anti-nkg2a agents and compositions and methods for making and using the same | |
| JP2007501601A5 (enExample) | ||
| EP1991577A2 (en) | Modulation of mdl-1 activity for treatment of inflammatory disease | |
| WO2006068326A1 (ja) | 新規ポリペプチドおよびその用途 | |
| JP2004535178A (ja) | 新規変異 | |
| US7709225B2 (en) | Nucleic acids encoding mutations in sodium channels related to epilepsy | |
| WO2002064787A1 (fr) | Neurotonine et utilisation |